An Anti-apoptotic Peptide Improves Survival in Lethal Total Body Irradiation
Overview
Authors
Affiliations
Cell penetrating peptides (CPPs) have been used to deliver the anti-apoptotic Bcl-xL-derived BH4 peptide to prevent injury-induced apoptosis both in vitro and in vivo. Here we demonstrate that the nuclear localization sequence (NLS) from the SV40 large T antigen has favorable properties for BH4 domain delivery to lymphocytes compared to sequences based on the HIV-1 TAT sequence. While both TAT-BH4 and NLS-BH4 protected primary human mononuclear cells from radiation-induced apoptotic cell death, TAT-BH4 caused persistent membrane damage and even cell death at the highest concentrations tested (5-10 microM) and correlated with in vivo toxicity as intravenous administration of TAT-BH4 caused rapid death. The NLS-BH4 peptide has significantly attenuated toxicity compared to TAT-BH4 and we established a dosing regimen of NLS-BH4 that conferred a significant survival advantage in a post-exposure treatment model of LD90 total body irradiation.
Nakajima T, Wang B, Ono T, Uehara Y, Nakamura S, Ichinohe K J Radiat Res. 2017; 58(4):421-429.
PMID: 28201773 PMC: 5570048. DOI: 10.1093/jrr/rrw133.
Matsuzaki-Horibuchi S, Yasuda T, Sakaguchi N, Yamaguchi Y, Akashi M J Radiat Res. 2014; 56(1):100-13.
PMID: 25359904 PMC: 4572601. DOI: 10.1093/jrr/rru094.
Role of circulating lymphocytes in patients with sepsis.
de Pablo R, Monserrat J, Prieto A, Alvarez-Mon M Biomed Res Int. 2014; 2014:671087.
PMID: 25302303 PMC: 4163419. DOI: 10.1155/2014/671087.
Plaunt A, Harmatys K, Wolter W, Suckow M, Smith B Bioconjug Chem. 2014; 25(4):724-37.
PMID: 24575875 PMC: 3993938. DOI: 10.1021/bc500003x.
Monaco G, Decrock E, Nuyts K, Wagner 2nd L, Luyten T, Strelkov S PLoS One. 2013; 8(8):e73386.
PMID: 24137498 PMC: 3795776. DOI: 10.1371/journal.pone.0073386.